Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)

ConditionsDepression Cancer Stage III Breast Cancer Stage II Breast Cancer Stage I Breast Cancer Stage III Prostate Cancer Stage II Prostate Cancer Stage I Prostate Cancer Stage III Colorectal Cancer Stage II Colorectal Cancer Stage I Colorectal Cancer

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

AgeNot listed

SponsorCase Comprehensive Cancer Center

About this trial

The purpose of this study is to develop and test a new intervention to reduce depressive symptoms in post-treatment cancer participants.

Eligibility criteria

Qualifiers

Self-reported mild to moderately-severe symptoms of depression (score 5-19 on PHQ-9).

A diagnosis of stage 0-III breast, prostate, or colorectal cancer.

Completion of primary cancer treatment within 2 years (excludes hormone therapy).

An ability to provide informed consent.

Disqualifiers

Self-reported minimal and severe depressive symptoms (<4 and > 20 on PHQ-9).

Self-reported suicidal ideation (>1 on item 9 PHQ-9).

Another psychological, medical, or other condition/issue determined that necessitates priority treatment and/or that would interfere with participation (e.g., schizophrenia, borderline personality disorder)

Current or recent substance abuse/dependence.

Trial design

Treatments tested in this trial

MINDSET
Enhanced Usual Care (EUC)

Treatment groups

76 Participants

are divided into 2 treatment groups

Locations

Case Comprehensive Cancer Center, Cleveland Clinic Foundation44195, ClevelandOhio, United States

Sponsors and collaborators

Case Comprehensive Cancer Center

Lead sponsor

Source ClinicalTrials.gov